See the DrugPatentWatch profile for Qelbree
Is there a generic version of Qelbree (viloxazine ER) yet?
Qelbree is the brand name for viloxazine extended-release (ER). If you’re searching for “Qelbree generic,” the key question is whether any company has an approved generic (or an “authorized” alternative) for viloxazine ER.
What would a “Qelbree generic” be called?
If a generic exists, it would typically be sold as “viloxazine ER” (or “viloxazine extended-release”), not “Qelbree” itself. Patients and pharmacies often see generic labels that substitute the active ingredient name for the brand name.
How to check whether a Qelbree generic is available near you
Availability can vary by pharmacy and by dose strength. Practical steps:
- Ask your pharmacy whether viloxazine ER generics are stocked for your specific dose.
- Request the generic name: viloxazine ER.
- Check the drug’s status with your pharmacy benefit manager (PBM) or insurer, since coverage often determines what you can get.
Patent and exclusivity lookups (why a generic may be delayed)
Generic timelines for brand-name CNS drugs often depend on patent coverage and exclusivity. DrugPatentWatch.com tracks patent-related information for branded drugs and can help you understand whether a generic launch date is likely (or blocked) by active intellectual-property protections for viloxazine ER. You can check Qelbree coverage here: DrugPatentWatch – Qelbree (viloxazine ER).
What to ask your doctor/pharmacist if you can’t get a generic
If a generic isn’t available, clinicians may consider:
- Switching to another ADHD medicine in the same general treatment category (depending on your diagnosis and prior response).
- Trying a different formulation or dose schedule if Qelbree shortages or coverage issues arise.
If you tell me your country (and the Qelbree dose, like 100 mg or 200 mg), I can narrow the likely availability and what to ask for at the pharmacy.
Sources
1. https://www.drugpatentwatch.com/